JSPR - Jasper Therapeutics, Inc.

QQQ $ 605.51 $ 0.00 (0 %)

DIA $ 464.38 $ 0.00 (0 %)

SPY $ 667.63 $ 0.00 (0 %)

TLT $ 90.98 $ 0.00 (0 %)

GLD $ 389.81 $ 0.00 (0 %)

Previous Close

$ 2.6

Open

$ 2.50

Bid

$ 2.46 x 200

Ask

$ 2.66 x 100

Day's Range

-- - --

52 Week Range

$ 2.22 - $ 26.05

Volume

480,380

Average Volume

Market Cap

39.87M

Beta (5Y Monthly)

$ 2.18

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	02-28-2025	01-01-1970	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	03-05-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-11-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-08-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-12-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-18-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-24-2021	03-31-2021	10-Q
19	03-30-2021	12-31-2020	10-K
20	11-10-2020	09-30-2020	10-Q
21	08-14-2020	06-30-2020	10-Q
22	05-13-2020	03-31-2020	10-Q
23	03-26-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Wednesday'...
09/24/2025 21:06:04

Evercore ISI Group Maintains Outperform on...
09/22/2025 15:00:00

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the ...

JMP Securities Maintains Market Outperform...
09/22/2025 13:22:25

JMP Securities analyst Silvan Tuerkcan maintains Jasper Therapeutics (NASDAQ:JSPR) with a Market Outperform and lowers the p...

BTIG Maintains Buy on Jasper Therapeutics,...
09/22/2025 09:36:45

BTIG analyst Justin Zelin maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $20 to $7.

12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

Jasper Therapeutics Announces $30M Public ...
09/19/2025 04:53:38

12 Health Care Stocks Moving In Thursday's...
09/18/2025 21:06:10

Jasper Therapeutics Announces Proposed Und...
09/18/2025 20:11:09

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on development of br...

UBS Maintains Buy on Jasper Therapeutics, ...
08/15/2025 14:21:43

UBS analyst Trung Huynh maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $29 to $25.

Jasper Therapeutics Q2 EPS $(1.74) Misses ...
08/13/2025 20:26:46

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(1.74) per share which missed the analyst consensus estimate of...

Jasper Therapeutics Announces 50% Workforc...
07/09/2025 12:14:22

Reducing workforce by approximately 50% to focus on Chronic Urticaria programs and extend cash runwayDr. Edwin Tucker departing...

BMO Capital Downgrades Jasper Therapeutics...
07/08/2025 17:48:59

BMO Capital analyst Kostas Biliouris downgrades Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform and lowe...

JMP Securities Maintains Market Outperform...
07/08/2025 14:11:14

JMP Securities analyst Silvan Tuerkcan maintains Jasper Therapeutics (NASDAQ:JSPR) with a Market Outperform and lowers the p...

Evercore ISI Group Maintains Outperform on...
07/08/2025 13:02:17

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the ...

William Blair Downgrades Jasper Therapeuti...
07/07/2025 21:20:51

William Blair analyst Matt Phipps downgrades Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform.

HC Wainwright & Co. Maintains Buy on Jaspe...
07/07/2025 20:47:40

HC Wainwright & Co. analyst Emily Bodnar maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price tar...

BTIG Maintains Buy on Jasper Therapeutics,...
07/07/2025 20:20:21

BTIG analyst Justin Zelin maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $64 to $20.

jasper-therapeutics-shares-fall-on-briquilimab-drug-lot-problem

Jasper Therapeutics Shares Fall On Briquil...
07/07/2025 17:25:33

Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and h...

12 Health Care Stocks Moving In Monday's I...
07/07/2025 17:06:57

Dow Dips 1%; Mustang Bio Shares Spike Higher
07/07/2025 16:30:43